Getinge downgraded to Neutral on mounting risks at Redburn

Redburn downgraded Getinge to Neutral from Buy with a price target of SEK 205, down from SEK 280. The analyst cites the increased quality control and supply chain challenges disclosed in the company’s Cardiopulmonary and Cardiac Assist businesses for the downgrade. With remediation required likely to last well into the first half of 2024, further delays and related costs can’t be ruled out, the analyst tells investors in a research note.